Skip to main content
. 2017 Nov 15;31(1):e00024-17. doi: 10.1128/CMR.00024-17

TABLE 4.

FDA-approved/cleared multiplex gastrointestinal panelsa

Parameter Verigene EP Luminex GPP BioFire GIP
Analysis platform Verigene system Magpix or Luminex 100/200 system FilmArray system or FilmArray Torch
Acceptable specimen type Stool in Cary-Blair medium Fresh stool or stool in Cary-Blair medium Stool in Cary-Blair medium
No. of targets 9 14 22
Ability to detect pathogen
    Bacteria
        Campylobacter species
        Salmonella species
        Shigella species/enteroinvasive E. colib
        Vibrio species
        Vibrio cholerae
        Yersinia enterocolitica
        Escherichia coli O157
        Enterotoxigenic E. coli
        Enteropathogenic E. coli
        Enteroaggregative E. coli
        Plesiomonas shigelloides
        Shiga toxin-producing E. coli (stx1-stx2) c
        Clostridium difficile (toxin A/B)
    Viruses
        Norovirus GI/GII
        Rotavirus A
        Astrovirus
        Adenovirus 40/41
        Sapovirus
    Parasites
        Cryptosporidium species
        Entamoeba histolytica
        Giardia lamblia
        Cyclospora cayetanensis
No. of samples (throughput) 1–32 (scalable) 24 1–12 (scalable)
Time to result (h) <2 ∼5 ∼1
a

EP, enteric pathogens; GPP, gastrointestinal pathogen panel; GIP, gastrointestinal panel.

b

The Verigene EP and Luminex GPP do not specifically target enteroinvasive E. coli.

c

The Verigene EP has separate targets for stx1 and stx2.